Covid vaccines for children likely by Sept: AIIMS chief

Trials for Bharat Biotech's Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All India Institute of Medical Sciences director Randeep Guleria......

8 vaccines, 4 treatments in India's COVID-19 arsenal

The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments......

Govt developing multi-variant Covid-19 vaccine

Government institutions and pharma industry are examining if a 'cocktail' approach to making a multi-variant Covid-19 vaccine works against multiple strains of the ever-mutating virus,......

Govt waives import duty on Remdesivir

Amid surging COVID-19 cases in the country, the government on Tuesday waived customs duty on Remdesivir, its raw materials and other components used to make the antiviral drug. The move would help......

Cadila plans captive units in PhaEZ Park

Cadila Pharmaceuticals has chalked out ambitious plans to set up close to eight units in its upcoming PhaEZ Park near Ahmedabad, which is touted to be the largest in India. "In all, we will invest......

Cadila to market anti-cancer drug by 2006

Cadila Pharmaceuticals Ltd on Monday said it would market anti-cancer drugs GCS (Granulocyte Colony Stimulating) Factor and GMCS (Granulocyte Macrophage Colony Stumating) Factor by 2006 end."The......

Cadila Pharma likely to go public

Indravadan A Modi, chairman of the Ahmedabad-based pharmaceutical major Cadila Pharmaceuticals, gave an indication for the first time on Friday that the company will go public in the near......

Cadila Pharma to enter skin care segment

The Ahmedabad-based Rs 550 crore (Rs 5.5 billion) Cadila Pharmaceuticals Lid has introduced its first skincare product, 'Umrela,' on Tuesday. The new launch is part if its strategy to enter the Rs......